Conclusions and Future Perspectives Overall, GLP-1RAs are considered novel blood glucose lowering drugs used in the treatment of T2MD (229), owing to their advantages of lowering blood pressure, lowering the levels of fasting blood glucose, lowering HbA1c, inducing weight loss, and being associated with a low incidence of hypoglycemia
Here, we addressed our mechanistic models experimentally using ScGrx7 as a reference enzyme 11,12,18
Although these medications dont typically produce the rapid 1520% average weight loss seen with GLP-1s, they can still lead to clinically meaningful reductions of about 510% of body weight, which can improve blood pressure, blood sugar, and cholesterol levels
Different GLP-1 receptor agonists have varying pharmacokinetic profiles, receptor binding affinities, and dosing schedules
Transform Your Vitality
1 2 "Boys hit by body blues"